If you invest in the stock market, you must know the Sun Pharma share price targets for 2026, 2027, 2028, 2029, 2030, 2040, and 2050. Here, you will get detailed information regarding all your queries, such as its fundamentals, shareholdings, financial performance, future predictions, and more.
Table of Contents
About Sun Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries Ltd is a leading pharmaceutical company in India known for making affordable generic medicines, specialty drugs, and healthcare products. It operates in many countries and focuses on high quality medicine manufacturing and global healthcare solutions. The company offers treatments for heart, skin, brain, and cancer care, making it important in the healthcare sector. Sun Pharma is popular among investors looking for pharma stocks, healthcare investment, and long term growth opportunities. With strong research, global reach, and trusted products, it plays a key role in the growing pharmaceutical industry.
Fundamental Analysis of Sun Pharma
- Market Cap: ₹4,17,556 Cr.
- High / Low: ₹1,851 / ₹1,547
- Stock P/E: 34.4
- Book Value: ₹324
- Dividend Yield: 0.92%
- ROCE: 20.2%
- ROE: 16.9%
- Face Value: ₹1
Sun Pharma Share Price Target 2026
After analysing past price trends and market performance, it is estimated that the Sun Pharma stock price could reach a minimum of ₹1500 and potentially achieve a maximum target of ₹2000 in the year 2026.
Sun Pharma Share Price Target 2027
After analysing past price trends and market performance, it is estimated that the Sun Pharma stock price could reach a minimum of ₹2000 and potentially achieve a maximum target of ₹2500 in the year 2027.
Sun Pharma Share Price Target 2028
After analysing past price trends and market performance, it is estimated that the Sun Pharma stock price could reach a minimum of ₹2500 and potentially achieve a maximum target of ₹3000 in the year 2028.
Sun Pharma Share Price Target 2029
After analysing past price trends and market performance, it is estimated that the Sun Pharma stock price could reach a minimum of ₹3000 and potentially achieve a maximum target of ₹3500 in the year 2029.
Sun Pharma Share Price Target 2030
After analysing past price trends and market performance, it is estimated that the Sun Pharma stock price could reach a minimum of ₹3500 and potentially achieve a maximum target of ₹4000 in the year 2030.
Sun Pharma Share Price Target 2040
After analysing past price trends and market performance, it is estimated that the Sun Pharma stock price could reach a minimum of ₹8000 and potentially achieve a maximum target of ₹9000 in the year 2040.
Sun Pharma Share Price Target 2050
After analysing past price trends and market performance, it is estimated that the Sun Pharma stock price could reach a minimum of ₹13000 and potentially achieve a maximum target of ₹15000 in the year 2050.
Shareholding Pattern of Sun Pharma
- Promoters: 54.48%
- Foreign Institutions: 15.93%
- Mutual Funds: 11.96%
- Other Domestic Institutions: 9.15%
- Retail and Others: 8.48%
Should You Invest in Sun Pharma Stock?
| Year | Target Price (₹) |
|---|---|
| 2026 | 1500–2000 |
| 2027 | 2000–2500 |
| 2028 | 2500–3000 |
| 2029 | 3000–3500 |
| 2030 | 3500–4000 |
| 2040 | 8000–9000 |
| 2050 | 13000–15000 |
Whether you should invest or not, it depends on the many factors. Let us know the risk and opportunities to invest in Sun Pharma stock.
Opportunities
- Strong global presence and trusted brand help attract investors searching for best pharma stocks and healthcare investment options
- Wide product portfolio including generic medicines and specialty drugs supports stable revenue growth over time
- Focus on research and innovation improves chances of new drug launches and long term business expansion
- Growing demand for affordable medicines worldwide supports strong sales and future growth potential
- Solid financial performance and export business make it a popular choice for long term stock investment
Risks
- Strict regulatory approvals and compliance issues can delay product launches and impact business growth
- High competition in generic medicine market can reduce profit margins and pricing power
- Currency fluctuations may affect earnings from international markets and exports
- Dependence on key markets like US can create risk if policies or demand change suddenly
- Legal challenges and patent issues can impact company reputation and stock price movement
Key Competitors of Sun Pharma
Key competitors or peer companies of Sun Pharma are Dr. Reddy’s Laboratories, Cipla, Lupin, Aurobindo Pharma, Zydus Lifesciences, Torrent Pharmaceuticals, Biocon, Glenmark Pharmaceuticals, Alkem Laboratories, and Divi’s Laboratories.
Disclaimer: All the information provided in this article is for educational purposes only. DateUpdateGo always advises seeking guidance from a certified financial advisor before making any investment-related decisions.
